Turn Therapeutics majority stake disclosed by Bradley Burnam

Turn Therapeutics Inc. reports a Schedule 13G showing Bradley Burnam holds 15,716,260 shares of common stock, representing 52.76% of the class.

Rhea-AI Filing Summary

Turn Therapeutics Inc. reports a Schedule 13G showing Bradley Burnam holds 15,716,260 shares of common stock, representing 52.76% of the class. The filing states these shares include options exercisable within 60 days and are held by BEB Holdings, LLC, of which Burnam is sole member. The company reported 29,788,040 shares outstanding as of March 30, 2026.

Insights

Governance Analyst

Major insider ownership disclosed: single holder controls a majority stake.

The filing shows 15,716,260 shares beneficially owned by Bradley Burnam via BEB Holdings, LLC, equal to 52.76% of the 29,788,040 shares outstanding as of March 30, 2026. This establishes clear voting control.

Concentration this large centralizes governance and decision authority. Future corporate actions that require shareholder approval will be strongly influenced by the reporting person. Subsequent public filings may show changes to this percentage if exercises or transfers occur.

Key Figures

Beneficial ownership: 15,716,260 shares Percent of class: 52.76% Shares outstanding: 29,788,040 shares +1 more

4 metrics

Beneficial ownership 15,716,260 shares Amount beneficially owned by Bradley Burnam as reported

Percent of class 52.76% Percent of common stock owned based on outstanding shares

Shares outstanding 29,788,040 shares Outstanding as of March 30, 2026 (used to compute percent)

Filing signature date 04/06/2026 Date the Schedule 13G was signed by Bradley Burnam

Key Terms

beneficially owned, sole voting and dispositive power, shares issuable upon exercise

3 terms

beneficially owned regulatory

"Amount beneficially owned: 15,716,260"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting and dispositive power governance

"The Reporting Person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power"

shares issuable upon exercise financial

"including shares issuable upon exercise of stock options that are exercisable within 60 days"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Bradley Burnam report in Turn Therapeutics (TTRX)?

Burnam reports beneficial ownership of 15,716,260 shares, or 52.76%. The shares are held by BEB Holdings, LLC; Burnam is the sole member and has sole voting and dispositive power, per the filing dated April 6, 2026.

How many Turn Therapeutics shares were outstanding for the ownership calculation?

The filing uses 29,788,040 shares outstanding as of March 30, 2026. The percent owned (52.76%) is the quotient of 15,716,260 divided by that outstanding share count, as stated in the filing.

Do the reported shares include exercisable options?

Yes — the holding includes shares issuable upon exercise of options exercisable within 60 days. The filing states those shares are held as of record by BEB Holdings, LLC and included in the beneficial ownership total.

Who holds voting and dispositive power over these shares?

Bradley Burnam is the sole member of BEB Holdings, LLC and has sole voting and dispositive power. The Schedule 13G states Burnam has sole power to vote and dispose of all 15,716,260 shares reported.

When was the Schedule 13G signed and filed by the reporting person?

The signature block shows Bradley Burnam signed the filing on April 6, 2026. That signature date is provided in the Item 10 certifications section of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/06/2026 - 08:05 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Turn Therapeutics Inc.

(Name of Issuer)

common stock

(Title of Class of Securities)

90021W105

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 90021W105

1

Names of Reporting Persons

Bradley Burnam

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 15,716,260.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 15,716,260.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

15,716,260.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

52.76 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The number in Rows (5), (7) and (9) consists of 15,716,260 shares of common stock, par value $0.0001 per share ("common stock"), of the Issuer, including shares issuable upon exercise of stock options that are exercisable within 60 days as of April 2, 2026 and held as of record by BEB Holdings, LLC. The Reporting Person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. The number in Row (11) is based on the quotient obtained by dividing (a) the aggregate number of shares of common stock beneficially owned by the Reporting Person as set forth in Row (9) by (b) the 29,788,040 shares of common stock outstanding as of March 30, 2026, as reported by the Issuer to the Reporting Person.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Turn Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 250 NORTH WESTLAKE BLVD., # 210, WESTLAKE VILLAGE, CA,91362
Item 2.
(a)	Name of person filing: Bradley Burnam
(b)	Address or principal business office or, if none, residence: C/O TURN THERAPEUTICS INC. 250 NORTH WESTLAKE BLVD., #210 WESTLAKE VILLAGE, CA, 91362
(c)	Citizenship: UNITED STATES
(d)	Title of class of securities: common stock
(e)	CUSIP Number(s): 90021W105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 15,716,260
(b)	Percent of class: 52.76%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 15,716,260
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 15,716,260
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Bradley Burnam

Signature:	/s/ Bradley Burnam
Name/Title:	Bradley Burnam
Date:	04/06/2026